Synergistic Effect of Mesangial Cell-Induced CXCL1 and TGF-β1 in Promoting Podocyte Loss in IgA Nephropathy

Podocyte loss has been reported to relate to disease severity and progression in IgA nephropathy (IgAN). However, the underlying mechanism for its role in IgAN remain unclear. Recent evidence has shown that IgA1 complexes from patients with IgAN could activate mesangial cells to induce soluble mediator excretion, and further injure podocytes through mesangial-podocytic cross-talk. In the present study, we explored the underlying mechanism of mesangial cell-induced podocyte loss in IgAN. We found that IgA1 complexes from IgAN patients significantly up-regulated the expression of CXCL1 and TGF-β1 in mesangial cells compared with healthy controls. Significantly higher urinary levels of CXCL1 and TGF-β1 were also observed in patients with IgAN compared to healthy controls. Moreover, IgAN patients with higher urinary CXCL1 and TGF-β1 presented with severe clinical and pathological manifestations, including higher 24-hour urine protein excretion, lower eGFR and higher cresentic glomeruli proportion. Further in vitro experiments showed that increased podocyte death and reduced podocyte adhesion were induced by mesangial cell conditional medium from IgAN (IgAN-HMCM), as well as rhCXCL1 together with rhTGF-β1. In addition, the over-expression of CXCR2, the receptor for CXCL1, by podocytes was induced by IgAN-HMCM and rhTGF-β1, but not by rhCXCL1. Furthermore, the effect of increased podocyte death and reduced podocyte adhesion induced by IgAN-HMCM and rhCXCL1 and rhTGF-β1 was rescued partially by a blocking antibody against CXCR2. Moreover, we observed the expression of CXCR2 in urine exfoliated podocytes in IgAN patients. Our present study implied that IgA1 complexes from IgAN patients could up-regulate the secretion of CXCL1 and TGF-β1 in mesangial cells. Additionally, the synergistic effect of CXCL1 and TGF-β1 further induced podocyte death and adhesion dysfunction in podocytes via CXCR2. This might be a potential mechanism for podocyte loss observed in IgAN.     

Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis

Background:

Recent guidelines suggest lowering the target blood pressure for patients with chronic kidney disease, although the strength of evidence for this suggestion has been uncertain. We sought to assess the renal and cardiovascular effects of intensive blood pressure lowering in people with chronic kidney disease.

Methods:

We performed a systematic review and meta-analysis of all relevant reports published between 1950 and July 2011 identified in a search of MEDLINE, Embase and the Cochrane Library. We included randomized trials that assigned patients with chronic kidney disease to different target blood pressure levels and reported kidney failure or cardiovascular events. Two reviewers independently identified relevant articles and extracted data.

Results:

We identified 11 trials providing information on 9287 patients with chronic kidney disease and 1264 kidney failure events (defined as either a composite of doubling of serum creatinine level and 50% decline in glomerular filtration rate, or end-stage kidney disease). Compared with standard regimens, a more intensive blood pressure–lowering strategy reduced the risk of the composite outcome (hazard ratio [HR] 0.82, 95% confidence interval [CI] 0.68–0.98) and end-stage kidney disease (HR 0.79, 95% CI 0.67–0.93). Subgroup analysis showed effect modification by baseline proteinuria (p = 0.006) and markers of trial quality. Intensive blood pressure lowering reduced the risk of kidney failure (HR 0.73, 95% CI 0.62–0.86), but not in patients without proteinuria at baseline (HR 1.12, 95% CI 0.67–1.87). There was no clear effect on the risk of cardiovascular events or death.

Interpretation:

Intensive blood pressure lowering appears to provide protection against kidney failure events in patients with chronic kidney disease, particularly among those with proteinuria. More data are required to determine the effects of such a strategy among patients without proteinuria.Chronic kidney disease is a major public health problem worldwide, affecting 10%–15% of the adult population.¹ Blood pressure–lowering agents are the mainstay of management strategies aiming to slow the progression of chronic kidney disease, as well as a core aspect of strategies aiming to reduce cardiovascular risk.^2–4 Observational studies have shown a log-linear increase in the risk of kidney failure with high blood pressure levels across the observed range,^5–7 suggesting that further lowering blood pressure could reduce the risk of kidney failure at most blood pressure levels. Current guidelines recommend a blood pressure target below 130/80 mm Hg for patients with chronic kidney disease,^8–10 but this recommendation is mostly based on observational studies and a single randomized trial (the Modification of Diet in Renal Disease [MDRD] study) that focused on kidney protection.¹¹ Subsequent trials of different targets in people with chronic kidney disease have yielded inconsistent results,^12,13,14 leading to criticism by the recent Canadian Hypertension Education Program guideline (which suggested a less aggressive target) of other guidelines, with suggestions that their blood pressure recommendations went beyond the available evidence. This criticism has been supported by a recent systematic review (no meta-analysis was performed) that focused on 3 trials and reported inconclusive results overall but raised the possibility that proteinuria was an effect modifier.¹⁵ The final result has been clinician uncertainty about optimal blood pressure levels in patients with chronic kidney disease.We sought to synthesize the results of all available trials that evaluated the effects of different blood pressure targets in people with chronic kidney disease and to better define the balance of risks and benefits associated with different intensities of blood pressure lowering in this population.     

Complete genome sequence of Lactobacillus delbrueckii subsp. bulgaricus strain ND02

Lactobacillus delbrueckii subsp. bulgaricus strain ND02 is a Chinese commercial dairy starter used for the manufacture of yoghurt. It was isolated from naturally fermented yak milk in Qinghai, China. Here, we report the main genome features of ND02 and several differences with two other published genomes of Lactobacillus delbrueckii subsp. bulgaricus strains.     

Further Insights into Metal-DOM Interaction: Consideration of Both Fluorescent and Non-Fluorescent Substances

Information on metal binding with fluorescent substances has been widely studied. By contrast, information on metal binding with non-fluorescent substances remains lacking despite the dominance of these substances in aquatic systems. In this study, the metal binding properties of both fluorescent and non-fluorescent substances were investigated by using metal titration combined with two-dimensional correlation spectroscopy (2D–COS) analysis. The organic matters in the eutrophic algae-rich lake, including natural organic matters (NOM) and algae-induced extracellular polymeric substances (EPS), both contained fluorescent and non-fluorescent substances. The peaks in the one-dimensional spectra strongly overlapped, while 2D–COS can decompose the overlapped peaks and thus enhanced the spectral resolution. Moreover, 2D FTIR COS demonstrated that the binding susceptibility of organic ligands in both NOM and algal EPS matrices followed the order: 3400>1380>1650 cm⁻¹, indicative the significant contribution of non-fluorescent ligands in metal binding. The modified Stern-Volmer equation also revealed a substantial metal binding potential for the non-fluorescent substances (logK_M: 3.57∼4.92). As for the effects of organic ligands on metal binding, EPS was characterized with higher binding ability than NOM for both fluorescent and non-fluorescent ligands. Algae-induced EPS and the non-fluorescent substances in eutrophic algae-rich lakes should not be overlooked because of their high metal binding potential.     

5种温带果树SRAP-PCR退火温度的优化

SRAP技术是一种多态性和信息量丰富的新型分子标记技术,近年来在植物遗传多样性分析、种质鉴定、遗传连锁图的构建以及比较基因组学研究等方面得到广泛应用.有关SRAP-PCR反应体系的优化很少涉及到退火温度.因此,我们利用梯度PCR技术,对SRAP-PCR过程中的两步退火温度进行了研究,以期获得较好的退火温度组合.通过对第一步前5轮循环的退火温度梯度37～50℃的实验,其退火温度可提高到41℃:对第二步后30轮循环的退火温度梯度50～60℃的实验,其退火温度可提高到52℃.应用该程序在苹果、桃、板栗、梨和樱桃等5个树种各4个品种进行扩增,均获得了良好的结果.     

Systemic induction of H2O2 in pea seedlings pretreated by wounding and exogenous jasmonic acid

Mechanical stress was one of stresses with whichplants often met. With the development of fruit andvegetable finish machining in food industry, artificialinjury also appeared. As response to other stresses,plants have evolved with some adaptive mechanismsto cope with wounding[1]. Jasmonic acid (JA) andmethyl jasmonate (MeJA), as important signal mole-cules in plant response to wounding, have attracted agreat deal of attention. The studies on some crops, suchas potato[2], rice[3], and tomato[…     

北玄参毛状根诱导及其植株再生

利用发根农杆菌A4和R1601感染北玄参(Scrophularia buergeriana)叶片外植体,诱导产生毛状根,产生的毛状根可在无激素的液体和固体MS培养基上快速生长。rol B基因的PCR检测表明,Ri质粒中的T-DNA片段整合到了北玄参毛状根的基因组中。毛状根在附加0.5 mg·L–1 6-BA及0.1 mg·L–1 NAA的MS固体培养基上形成绿色愈伤组织,之后形成不定芽,并获得再生植株;毛状根在附加0.5 mg·L–1 6-BA及0.02 mg·L–1 NAA的MS固体培养基上培养约15–20天可直接形成不定芽,且不定芽的诱导率达85%。     

Modulating Plasmonic Sensor with Graphene-Based Silicon Grating

We propose a modulating plasmonic structure device which is composed of a single layer graphene above the silicon Bragg grating with the silica spacer layer. This graphene-based plasmonic modulation provides a broad stop-band with high tunability in the mid-infrared region of the transmission spectra achieved by altering the geometrical parameters of the silicon grating and the gate voltage. By engineering, a phase discontinuity into the graphene-based Bragg grating, we can selectively open a transmission window in the previous stop-band spectra. These proposed graphene-based structures are easy to fabricate and operate, which have potential applications as ultra-compact high-sensitivity sensors.     

Influence of frequency and temperature on the mechanisms of nerve conduction block induced by high-frequency biphasic electrical current

The influences of stimulation frequency and temperature on mechanisms of nerve conduction block induced by high-frequency biphasic electrical current were investigated using a lumped circuit model of the myelinated axon based on Schwarz and Eikhof (SE) equations. The simulation analysis showed that a temperature-frequency relationship was determined by the axonal membrane dynamics (i.e. how fast the ion channels can open or close.). At a certain temperature, the axonal conduction block always occurred when the period of biphasic stimulation was smaller than the action potential duration (APD). When the temperature decreased from 37 to 15 degrees C, the membrane dynamics slowed down resulting in an APD increase from 0.4 to 2.4 ms accompanied by a decrease in the minimal blocking frequency from 4 to 0.5 kHz. The simulation results also indicated that as the stimulation frequency increased the mechanism of conduction block changed from a cathodal/anodal block to a block dependent upon continuous activation of potassium channels. Understanding the interaction between the minimal blocking frequency and temperature could promote a better understanding of the mechanisms of high frequency induced axonal conduction block and the clinical application of this method for blocking nerve conduction.